Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00032357 · ClinicalTrials.gov registry record · Phase 3
Does the Reduction of Total Body Iron Storage (TBIS) Alter Mortality in a Population of Patients With Advanced PVD?
A Phase 3 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,277
- Enrollment target
NCT00032357 is a Phase 3 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 1,277 participants.
The verdict
NCT00032357, a Phase 3 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,277 participants
- Enrollment target
Study Summary
Veterans Affairs Cooperative Study #410, The Iron and Atherosclerosis Trial, FeAST, a 24-hospital prospective randomized single-blinded clinical trial of graded iron reduction was conducted between May 1, 1999 and April 30, 2005, and has now been completed. A total of 1,277 primarily male participants with peripheral arterial disease were entered. The primary outcome was all cause mortality and the secondary outcome combined death plus non-fatal myocardial infarction (MI) and stroke.
Interventions
- PROCEDURE Ferritin reduction to 25 ng/ml by phlebotomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,277 participants |
| Start Date | 1999-05 |
| Est. Completion | 2005-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00032357
The ClinicalTrials.gov registry entry for NCT00032357 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,277 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ferritin reduction to 25 ng/ml by phlebotomy is the first listed.
NCT00032357 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00032357 about?
NCT00032357 is a clinical study titled "Does the Reduction of Total Body Iron Storage (TBIS) Alter Mortality in a Population of Patients With Advanced PVD?". Veterans Affairs Cooperative Study #410, The Iron and Atherosclerosis Trial, FeAST, a 24-hospital prospective randomized single-blinded clinical trial of graded iron reduction was conducted between May 1, 1999 and April 30, 2005, and has now been completed. A total of 1,277 primarily male participan...
What is the current status of trial NCT00032357?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,277 participants. The study started on 1999-05. Estimated completion is 2005-09.
What interventions are being tested in trial NCT00032357?
The interventions under investigation include: Ferritin reduction to 25 ng/ml by phlebotomy (PROCEDURE).
Who is sponsoring clinical trial NCT00032357?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.